CardioVascular BioTherapeutics (fka CVBT)

[johnnyblades2001]

Patent Edition FAKE NEWS AGAIN: Examples inside

Let me point out several examples of development stage Biotech companies with No Revenues and No Approved products that were afforded valuations in the BILLIONS

Avexis was a clinical stage biotech company that was purchased Novartis for 8.7 Billion. One patent, one drug in development.


Heres one where Pfizer paid almost a billion in upfront and milestone payments for Therachon using a form of FGF. No revenues, no approved products.

https://investors.pfizer.com/investor-news/press-release-details/2019/Pfizer-Acquires-Clinical-Stage-Biotech-Therachon/default.aspx

Here is an article directly dispute the Patent fake news put forth by some. Explaining why valuing Biotechs is different than other companies.

https://www.toptal.com/finance/valuation/biotech-valuation


Gilead bought Kite Pharma - no revenue, no products, paid $12 billion and Kite Pharma was $600 million in the hole.

There are many, many, many other examples. A quick Google search should surface a number of them.